TriSalus Life Sciences Inc. (TLSI) — Financial Flexibility Index
TriSalus Life Sciences Inc. (TLSI) has a Financial Flexibility Index of -0.29x as of June 2026. Free cash flow of $-16.39 Million (operating CF $-16.61 Million minus capex $223.00K) represents 0% of total liabilities ($55.90 Million). Check TLSI goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
TriSalus Life Sciences Inc. Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for TriSalus Life Sciences Inc. across 5 annual periods. For the full cash flow conversion analysis, see TLSI operating cash flow.
Annual Financial Flexibility Index for TriSalus Life Sciences Inc. (2021–2025)
Year-by-year free cash flow to debt coverage for TriSalus Life Sciences Inc.. Explore cash flow to debt ratio of TriSalus Life Sciences Inc. to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.25x | $-17.09 Million | $-18.01 Million | $69.19 Million | ▲ +69.6% |
| 2024 | -0.81x | $-40.50 Million | $-40.84 Million | $49.87 Million | ▲ +16.1% |
| 2023 | -0.97x | $-49.99 Million | $-50.58 Million | $51.66 Million | ▼ -5.3% |
| 2022 | -0.92x | $-31.53 Million | $-32.31 Million | $34.32 Million | ▲ +70.3% |
| 2021 | -3.09x | $-21.44 Million | $-22.70 Million | $6.93 Million | — |